flow study glp 1 In FLOW, semaglutide, a GLP-1 RA, reduced the risk of major kidney outcomes, MACE and all-cause mortality in people with T2D and CKD, regardless of baseline mineralocorticoid receptor antagonist use. @ADA_Pubs Read GLP-1s and beyond: Precision flow

Glutathione supports cellular detoxification through a process called conjugation

Vitamin B12 helps in healthy regulation of the nervous system, reducing depression, stress and brain shrinkage

Minireview: metabolism of female reproduction: regulatory mechanisms and clinical implications

With liraglutide established as an effective treatment that also addresses the dysmetabolic prediabetic-like state that characterizes these patients, it is my hope that physicians will have the condition on their radar and discuss this new treatment option with relevant patients

Whether you prefer Monday mornings or Friday evenings, picking a day you'll actually remember reduces accidental early or late doses